HOW TO GIVE | NEWS CENTER | FAITH AT ALEGENT                   
     
Register  |  
Sign In
 
               
 
 
  Breaking Health News
Print    Email     RSS       

Scientists ID Protein Aiding Breast Cancer Spread

Called Menainv, research suggests it's a promising candidate as marker for metastasis

MONDAY, Dec. 8 (HealthDay News) -- A protein that may contribute to the spread of breast cancer has been identified by U.S. researchers.

The protein (called Menainv) is present in invasive cells within a breast tumor. The protein may prove useful as a biomarker for metastatic breast cancer, the scientists said.

These invasive cells move into surrounding tissue and eventually to blood vessels, which provide the cancer cells with a means of moving to other areas of the body. Menainv is not present in noninvasive cancer cells that stay put in a breast tumor.

This is the first study to identify a protein that contributes to the invasive and metastatic ability of tumor cells, rather than "bystander" proteins that show up when cancer cells are invading other tissues, according to the researchers from the Albert Einstein College of Medicine and the Massachusetts Institute of Technology.

"We have micro-needles filled with growth factors and tissue that we insert into a tumor on an anesthetized mouse. If a cell is invasive, within four hours, it will crawl into the needles. We found that mouse breast tumor cells that we engineered to contain Menainv were invasive, whereas cells that did not have Menainv were not," study primary co-author Evanthia T. Roussos, an M.D.-Ph.D. student, said in an Albert Einstein news release.

The researchers also found that tumor cells with Menainv are less likely to be responsive to newer breast cancer treatments that inhibit receptors for epidermal growth factor (EGF), which has been shown to increase a breast cancer cell's invasive potential.

Drugs that inhibit EGF may not be effective against cancer cells that express Menainv, the researchers said. That's because tumor cells with Menainv are so sensitive to EGF that even a small amount of EGF signal not blocked by the drugs may be enough to stimulate EGF receptors and promote tumor cell migration and metastasis.

The study was published in the Dec. 8 issue of Developmental Cell.

More information

The U.S. National Cancer Institute has more about breast cancer.


SOURCE: Albert Einstein College of Medicine, news release, Dec. 8, 2008

Copyright © 2008 ScoutNews, LLC. All rights reserved.

 
Contact Us | Site Map | Privacy Notice | Terms of Use | Website Feedback |   RSS   | Alegent Mobile | Blogs | Podcasts | Video | eNewsletters
Alegent Health is a faith-based, health ministry sponsored by Catholic Health Initiatives and Immanuel Health Systems.
© 2009 Alegent Health. All rights reserved
http://www.alegent.com/body.cfm?id=4794